Latest News for: biogen inc.

Edit

There's a $1 trillion opportunity brewing in the stock market — and it's got nothing ...

Business Insider 21 Mar 2025
There's a $1 trillion opportunity brewing in the stock market ... Biogen Inc. Ticker. BIIBDoorDash, Inc ... EHCEyePoint Pharmaceuticals, Inc ... EYPTThe Home Depot, Inc ... HDRobinhood Markets, Inc ... GKOSRockwell Automation, Inc ... SMPLWelltower, Inc ... WELLVentas, Inc ... ....
Edit

Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | ...

GetNews 20 Mar 2025
... Alterity Therapeutics, Brain Neurotherapy Bio, Inc., Biogen, Corestem, Inc., ProMIS Neurosciences, FAScinate Therapeutics, Wren Therapeutics, Blade Therapeutics, Stealth BioTherapeutics, and others.
Edit

Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Epidemiology, Prevalence, Therapies ...

GetNews 17 Mar 2025
Leading Multiple Sclerosis companies working in the market are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., Bristol-Myers Squibb, TG Therapeutics, Inc., ...
Edit

Plaque Psoriasis Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Sun Pharma, Bristol-Myers ...

GetNews 13 Mar 2025
... Samsung Bioepis Co., Ltd, Durect, Astellas, Biogen, Dow Pharmaceutical Sciences, Shire, Zalicus, AbbVie, Santalis Pharmaceuticals Inc, Maruho Co Ltd, Novartis, AstraZeneca, Pfizer, and others.
Edit

Biogen to Participate in the Stifel 2025 Virtual CNS Forum (Biogen Inc)

Public Technologies 11 Mar 2025
Cambridge, MA, - - Biogen Inc ... To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com ... About Biogen. Founded in 1978, Biogen is a ... Biogen ... Biogen Inc.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Biogen Inc)

Public Technologies 10 Mar 2025
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104. Estimated average burden hours per response... 0.5. (Print or Type Responses) 1. Name and Address of Reporting Person *. Godbout Sean. 2 ... BIOGEN INC ... Biogen Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Biogen Inc)

Public Technologies 10 Mar 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number. 3235-0287 ... 0.5 ... 2 ... BIOGEN INC ... BIOGEN INC., 225 BINNEY STREET 3 ... BIOGEN INC ... Biogen Inc.
Edit

Oligonucleotide Synthesis Market worth $19.7 billion by 2029 | MarketsandMarkets™

GetNews 05 Mar 2025
Some leading players operating in the oligonucleotide synthesis market are Danaher Corporation (US), Thermo Fisher Scientific Inc ... (US), Azenta, Inc ... Major players in the oligonucleotide therapeutics market are Biogen Inc.
Edit

Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia

Pharmiweb 04 Mar 2025
Haruo Naito, “Eisai”) and Biogen Inc ... Viehbacher, “Biogen”) announced today that the Therapeutic Goods Administration (TGA) of ... Eisai Inc ... Biogen Inc ... [email protected] ... Biogen Inc ... [email protected].
Edit

Severe Asthma Market Expected to rise, 2034 | AstraZeneca plc, GlaxoSmithKline plc, Sanofi S.A., Novartis ...

GetNews 03 Mar 2025
... Incorporated, Amgen Inc., AbbVie Inc., Genentech, Inc., Gilead Sciences, Inc., Biogen Inc., CSL Limited, and others, are developing novel products to improve the Severe Asthma treatment outlook.
Edit

Oligonucleotide API Market Set for Strong Growth Amid Rising Drug Development Needs

Pharmiweb 03 Mar 2025
Oligonucleotide API Market ... Expansion of Biopharmaceutical Research ... Key Companies in the Market Jazz Pharmaceuticals, Inc. Sarepta Therapeutics Biogen Dynavax Technologies Akcea Therapeutics. Alnylam Pharmaceuticals, Inc ... Future Market Insights Inc ... T ... .
Edit

Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia (Biogen Inc)

Public Technologies 03 Mar 2025
Haruo Naito, "Eisai") and Biogen Inc ... Eisai Inc ... Biogen Inc ... [email protected] ... Biogen Inc ... [email protected] ... About the Collaboration between Eisai and Biogen for AD ... About Biogen ... Biogen Safe Harbor ... Biogen Inc.
×